arrow
M

Matthias Preusser

Medical University of Vienna
H指数:96
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors

全身炎症和患者报告的生活质量作为实体肿瘤患者的联合预后指标

2026-10-140
OAAI
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma

替莫唑胺相关血液学毒性与新诊断胶质母细胞瘤患者健康相关生活质量(HRQoL)的关联

2026-09-080
PRE
Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes

接受免疫检查点抑制剂与化疗的癌症患者血浆蛋白质组谱的显著变化:对血栓风险和不良结局的启示

2026-08-270
OAAI
ESTRO, ESNR, and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumors

ESTRO、ESNR和EORTC基于共识的颅内中枢神经系统肿瘤放疗后MRI异常定义

2026-08-200
PRE
PET RANO 1.0 vs RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: A retrospective, comparative study

PET RANO 1.0与RANO 2.0标准在IDH野生型胶质母细胞瘤临床试验入组资格中的应用:一项回顾性比较研究

2026-08-140
PRE
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy

颅脑放射治疗后进展性脑转移瘤的免疫重塑与分子特征分析

2026-08-010
PRE
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology and European Association of Neuro-Oncology consensus review on clinical management and future directions

BRAF突变型胶质瘤在成人和儿童中的研究:神经肿瘤学会和欧洲神经肿瘤学会关于临床管理与未来方向的共识综述

2026-06-080
OAAI
Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency department

来自三级学术中心的真实世界证据:急诊科就诊的肿瘤患者发热性中性粒细胞减少症的临床特征、微生物学和结局

2026-05-270
OAAI
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification

微环境确定的风险连续体可改善脑膜瘤的亚型,并揭示基于机器学习的肿瘤分类的决定因素

2026-02-090
OAAI
From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials

从同情用药到高级别证据:放射性药物疗法在复发脑膜瘤中的应用——LUMEN-1和MOMENTUM-1试验

2026-01-010
PRE
Targeted therapies in optic pathway gliomas

视路胶质瘤的靶向治疗

2025-12-270
OAAI
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges

离体药物筛选在患者来源肿瘤材料中的应用,以推进肿瘤学中的功能性精准医学:当前方法与未解决挑战概述

2025-12-220
OAAI
The evolving landscape of brain metastasis: volume II

脑转移的演变景观: 第二卷

2025-12-020
OAAI
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床潜力

2025-11-180
OAAI